Flora Growth Corp. (FLGC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Flora Growth Corp. (FLGC:NASDAQ), powered by AI.

Current Price
$5.62
P/E Ratio
-0.1
Market Cap
2M
Sector
Healthcare
What is the Flora Growth Corp. stock price forecast?

Flora Growth Corp. is currently trading at $5.62. View real-time AI analysis on Alpha Lenz.

What is Flora Growth Corp. insider trading activity?

View the latest insider trading data for Flora Growth Corp. on Alpha Lenz.

What is Flora Growth Corp.'s P/E ratio?

Flora Growth Corp.'s P/E ratio is -0.1.

Flora Growth Corp.

$5.62
NASDAQFLGC
Ask about Flora Growth Corp.'s future dividend policy...
Alpha Chat Insight

Flora Growth Corp. trades at a P/E of -0.1 (undervalued) with modest ROE of -291.5%. 3Y revenue CAGR of 87.8% highlights clear growth momentum.

Ask for details

Company Overview

Flora Growth Corp. is a company engaged in the cultivation and distribution of cannabis products. Operating with a focus on sustainable and natural practices, Flora Growth Corp. emphasizes an approach rooted in organic cannabis propagation. The company works across various segments, including pharmaceuticals, cosmetics, and consumer packaged goods, contributing to an expansive influence in both medical and recreational cannabis markets. Its supply chain is designed to provide cost-effective solutions across international borders, catering to diverse consumer needs. Flora Growth Corp. takes advantage of its operations in Colombia, a location known for its ideal climatic conditions for cannabis cultivation, which supports high-quality product output. As the global cannabis industry continues to evolve, Flora Growth Corp. plays a significant role in the expansion of cannabis-derived products, enhancing accessibility and acceptance of cannabis uses across multiple sectors. Its presence underscores a commitment to advancing sustainable industry practices while tapping into key trends in health and wellness sectors.

CEOMr. Clifford A. Starke
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees64

Company Statistics

(FY 2024)

Profile

Market Cap$1.77M
Revenue$59.51M
Shares Out0.00
Employees64

Margins

Gross21.00%
EBITDA-20.55%
Operating-21.84%
Pre-Tax-27.03%
Net-26.73%

Valuation

P/E-0.11
P/B0.39
EV/Sales0.03
EV/EBITDA-0.05
P/FCF-0.34

Growth (CAGR)

Rev 3Yr87.83%
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-63.82%
ROE-291.50%
ROIC-63.67%

Financial Health

Cash & Cash Equivalents$6.02M
Net Debt$15.70M
Debt/Equity481.53%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Flora Growth Corp. (Healthcare) Stock Forecast & Analysis $5.62 | Alpha Lenz